Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJF2G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,589
Award facts
- Contract value 100% obligated
- $15,589.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,589.03 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packaging) on December 26, 2025, with completion targeted for December 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
RINVOQ (upadacitinib) is a JAK inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the pharmaceutical distributor's role in supplying specialized medications to support military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp provides comprehensive pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and medical devices—across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of competitively awarded delivery orders.
Quick answers
Who was awarded contract SPE2DR26FJF2G?
SPE2DR26FJF2G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DR26FJF2G worth?
The government has obligated $15,589 on SPE2DR26FJF2G.
Is contract SPE2DR26FJF2G an order under another contract?
Yes. SPE2DR26FJF2G is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJF2G competed?
The extent of competition for SPE2DR26FJF2G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award